Minh-Patrick Le

20PUBLICATIONS
48CO-AUTHORS
PharmacogenomicsPsychosocial aspects of childbirth and perinatal mental healthMedical microbiology not elsewhere classifiedMedical infection agents (incl. prions)Molecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Oct 07, 2026
Efficacy and safety of switching to once-daily oral doravirine plus raltegravir in virologically suppressed people with HIV-1: a randomized, open-label, multicentre phase 2 study (DORAL).

|May 22, 2026
External Evaluation of Population Pharmacokinetic Models of Cabotegravir, During Its Oral and Intramuscular Administration in HIV-Infected Patients.

|Dec 17, 2025
Maternal-Fetal Letermovir Exposure In Vivo and Physiologically Based Pharmacokinetic Modeling: A Rationale for Congenital Cytomegalovirus Therapy.

Valentine Faure Bardon, Naim Bouazza, Gilles Peytavin

|Aug 18, 2025
Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With HIV-1: First Results From the ANRS-MIE CARLAPOP Study.

Nadège Néant, Minh P Lê, Stéphane Bouchet

|Jul 09, 2025
Insufficient cerebrospinal fluid penetration of tedizolid: a case report.

Xavier Brousse, Minh P Lê, Marin Lahouati

|Jun 30, 2025
Eravacycline as a last resort for difficult-to-treat resistant Acinetobacter baumannii infections in critically ill patients: three case reports with pharmacokinetic insights.

Leo Mimram, Jean-François Timsit, Emilie Rondinaud

Pageof 4

Frequent Collaborators

13 joint publications

Gilles Peytavin

4 joint publications

Florian Lemaitre

4 joint publications

Caroline Solas

3 joint publications

Jean-François Timsit